tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Westenberg, 99 are a BUY (66.89%), 43 are a HOLD (29.05%), 6 are a SELL (4.05%).
Analyst David Westenberg works at PIPER SANDLER with a stock forecast success ratio of 52.11% fulfilled within 105.33 days on average.
David Westenberg’s has documented 305 price targets and ratings displayed on 21 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on NEOG, Neogen at 15-Apr-2024.
Analyst best performing recommendations are on OCX (ONCOCYTE CORP).
The best stock recommendation documented was for OCX (ONCOCYTE CORP) at 11/13/2023. The price target of $3 was fulfilled within 1 day with a profit of $0.24 (8.7%) receiving and performance score of 86.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
35
$14.44 (70.23%)
45
4 months 17 days ago
0/4 (0%)
$8.4 (31.58%)
Hold
37
$16.44 (79.96%)
37
6 months 8 days ago
2/9 (22.22%)
$11.87 (47.23%)
88
Buy
125
$104.44 (507.98%)
141
2 years 2 months 30 days ago
3/7 (42.86%)
$61.5 (96.85%)
87
Buy
140
$119.44 (580.93%)
140
2 years 8 months 14 days ago
6/9 (66.67%)
$42.66 (43.83%)
90
Sell
65
$28.11 (76.20%)
55
2 years 8 months 14 days ago
6/8 (75%)
$-21.64 (-24.36%)
252
Which stock is David Westenberg is most bullish on?
Which stock is David Westenberg is most reserved on?
What Year was the first public recommendation made by David Westenberg?
